| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |